Careers  |  Sign In  |  Register

Latest in Internal Medicine

Current therapeutic options for non-small cell lung cancer (NSCLC) are ever-evolving with the possibility of solely immunotherapy-based treatment regimens on the near horizon for certain patients.
Nicotinamide riboside appears to be the best precursor supplement available to help maintain or increase NAD+ levels. All cells and tissues can use it, and at high doses it neither causes flushing nor inhibition of protective sirtuin enzymes.
Information would be safe from magnetism, but what about mutations?